Everyone s been there; it s a weekend or a weekday evening, your doctor s office is closed and you or a family member are experiencing symptoms that may be serious or may not be.
While a trip to the ER might give you peace of mind, there are lots of reasons people tend to avoid it from copays to wait times to possible exposure to viruses like COVID-19. If you ve ever wondered whether a trip to the emergency room is necessary particularly during a pandemic it s important to recognize the kinds of symptoms that require immediate medical help.
So don t think twice; head straight to the ER if you or a family member experiences any of the following symptoms.
Feb 17, 2021, 16:52 PM IST
People with cardiovascular risk factors also exhibit a low metabolism in brain regions, according to a study published in the Journal of the American College of Cardiology (JACC). The study claims that early intervention to prevent cardiovascular diseases can also help in the prevention of dementia and Alzheimers.
“Although everybody knows about the importance of caring for ourselves and controlling cardiovascular risk factors in order to avoid a heart attack, the association of these same risk factors with cognitive decline may increase awareness of the need to acquire healthy habits from the earliest stages of life,” says Dr Valentín Fuster, the lead author of the study.
Ivabradine Knocks Down Heart Rate, Symptoms in POTS medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Teleflex Completes Enrollment in CTO-PCI IDE Study
Enrollment Completed Ahead of Schedule in Study Evaluating the Performance of Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Interventions
WAYNE, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in a clinical study evaluating the performance of Teleflex specialty catheters and coronary guidewires in Chronic Total Occlusion (CTO) percutaneous coronary intervention (PCI) procedures currently an investigational indication for these products. The study enrolled 150 patients across 13 investigational sites in the US and completed enrollment three months ahead of schedule. The CTO-PCI study is a prospective, single-arm IDE study employing the primary angiographic endpoint of successful (intralumenal) guidewire placement beyond the CTO.
scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors
February 17, 2021 08:00 ET | Source: scPharmaceuticals, Inc. scPharmaceuticals, Inc. Burlington, Massachusetts, UNITED STATES
BURLINGTON, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the appointment of William T. Abraham, M.D., to the company’s Board of Directors. Dr. Abraham currently serves as Professor of Internal Medicine (Cardiology), Physiology and Cell Biology and College of Medicine Distinguished Professor at The Ohio State University as well as Chief Medical Officer at V-Wave Ltd., a privately held developer of percutaneous implantable therapeutic devices for